Please use this identifier to cite or link to this item: http://hdl.handle.net/10201/29665

Title: Gold complexes as prospective metal-based anticancer drugs
Issue Date: 2008
Publisher: Murcia : F. Hernández
ISSN: 0213-3911
Related subjects: 616 - Patología. Medicina clínica. Oncología
Keywords: Gold complexes
Anticancer drugs
Abstract: Medical and therapeutic value of gold has been recognized thousands of years ago, but its rational use in medicine has not begun until the early 1920s. Cisplatin is one of the first metal-containing compounds with anti-cancer activity discovered in the 1960s. Despite the fact that cisplatin treatment is efficient for several types of solid tumors, its effectiveness is limited by toxic side effects and tumor resistance that often leads to the occurrence of secondary malignancies. Since gold(III) is isoelectronic with platinum(II) and tetracoordinate gold(III) complexes have the same square-planar geometries as cisplatin, the anticancer activity of gold(III) compounds has been investigated. Previous studies suggested that, in contrast to cisplatin, gold complexes target proteins but not DNA. Recently, we have investigated gold(III) dithiocarbamates for their anticancer activity and showed that their primary target is the proteasome. Treatment of human breast tumorbearing nude mice with a gold(III) dithiocarbamate complex resulted in significant inhibition of tumor growth, associated with proteasome inhibition and massive apoptosis induction in vivo. Better understanding of physiological processing of gold compounds will provide a rational basis for their further development into novel anticancer drugs.
Primary author: Milacic, Vesna
Fregona, D.
Dou, Q.P.
Published in: Histology and histopathology
URI: http://hdl.handle.net/10201/29665
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 8
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.23, nº1 (2008)

Files in This Item:
File Description SizeFormat 
Gold complexes as prospective metal-based anticancer drugs.pdf457,89 kBAdobe PDFView/Open


Items in Digitum are protected by copyright, with all rights reserved, unless otherwise indicated.